Reducing harm from tobacco smoke exposure during pregnancy.
In addition to the health risks that maternal tobacco smoke exposure in pregnancy poses to women, this is a cause of substantial fetal morbidity and mortality. In pregnancy, maternal tobacco smoke exposure can arise because women either smoke or are passively exposed to environmental tobacco smoke as a consequence of other's smoking. This article discusses the scope for clinicians to help reduce both types of tobacco smoke exposure in pregnancy, with a specific focus on available and effective interventions for smoking cessation by pregnant women. Behavioral support with smoking cessation is the only intervention that has been proven to encourage smoking cessation in pregnancy and reduces smoking rates in late pregnancy by 6 to 7%. There are physiological reasons to suspect that nicotine replacement therapy (NRT) will be less or (in)effective for smoking cessation in pregnancy when compared with its use by nonpregnant smokers. However, there are also strong theoretical reasons to suspect that NRT is likely to be safer than continued smoking in pregnancy. Consequently, this article reviews evidence for the safety and effectiveness of NRT when used for smoking cessation in pregnancy and recommendations concerning the use of NRT in pregnancy are presented.
Coleman
Tim
T
Division of Primary Care, Queen's Medical Centre, University of Nottingham Medical School, Nottingham, United Kingdom. tim.coleman@nottingham.ac.uk
D005260:Female; D006801:Humans; D018811:Maternal Exposure / Q000517:prevention & control*; D011247:Pregnancy; D014028:Tobacco Smoke Pollution
D014028:Tobacco Smoke Pollution